HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): a caution.

Abstract
Ascites becomes refractory to medical treatment in nearly 10% of cirrhotic patients, who then require repeated large-volume paracentesis. In this prospective study we evaluated the use of transjugular intrahepatic portosystemic shunt (TIPS) in 30 patients with refractory ascites. TIPS was successful in all and resulted in a 54% reduction in portacaval gradient (from 22.8 +/- 0.8 to 10.4 +/- 0.6 mm Hg). Ascites became easily controlled with diuretics in 26 patients following TIPS. Ascites recurrence associated with shunt stenosis was observed during follow-up in eight patients; revision could be undertaken in five of them and resulted in good control of ascites. In responders, a marked decrease in plasma aldosterone and renin activity, a reduction in serum creatinine, and a rise in urinary sodium excretion were observed. Creatinine and inulin clearances improved significantly; PAH clearance remained unchanged. However, new-onset or worsening hepatic encephalopathy was seen in 14 patients. Severe disabling chronic encephalopathy occurred in five patients; it could be reversed successfully by balloon occlusion of the shunt in three. The cumulative survival rate was 41 and 34% at 1 and 2 years, respectively. In summary, TIPS can control refractory ascites in a majority of patients but is associated with a high rate of chronic disabling HE. In addition, the survival rate is poor. Randomized trials are needed to evaluate the exact role of TIPS in the management of refractory ascites. It is unlikely to improve survival but can ameliorate quality of life in nontransplant candidates and be useful as a bridge to transplantation, in particular, to improve denutrition associated with longstanding tense ascites.
AuthorsJ P Martinet, D Fenyves, L Legault, L Roy, M P Dufresne, L Spahr, M Lafortune, G Pomier-Layrargues
JournalDigestive diseases and sciences (Dig Dis Sci) Vol. 42 Issue 1 Pg. 161-6 (Jan 1997) ISSN: 0163-2116 [Print] United States
PMID9009133 (Publication Type: Journal Article)
Chemical References
  • Diuretics
  • Aldosterone
  • Sodium
  • Creatinine
  • Renin
Topics
  • Aged
  • Aldosterone (blood)
  • Ascites (etiology, metabolism, mortality, surgery)
  • Creatinine (blood)
  • Diuretics (adverse effects, therapeutic use)
  • Female
  • Hepatic Encephalopathy (etiology)
  • Humans
  • Hypertension, Portal (complications)
  • Liver Cirrhosis (complications)
  • Male
  • Middle Aged
  • Pilot Projects
  • Portasystemic Shunt, Transjugular Intrahepatic
  • Prospective Studies
  • Recurrence
  • Renin (blood)
  • Sodium (urine)
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: